Safety of COVID-19 vaccination in patients with clonal mast cell disorders

被引：8
|
作者：
Ruano-Zaragoza, Maria [1 ,2 ]
Carpio-Escalona, Laura V. [3 ]
Diaz-Beya, Marina [4 ]
Piris-Villaespesa, Miguel [5 ]
Castano-Diez, Sandra [4 ]
Munoz-Cano, Rosa [1 ,2 ]
Gonzalez-de-Olano, David [2 ,3 ]
机构：
[1] Univ Barcelona, Hosp Clin, Allergy Sect, IRCE Inst dInvest Biomed August Pi Sunyer, C Villarroel,170, Barcelona 08036, Spain
[2] Inst Salud Carlos III, ARADyAL, Madrid, Spain
[3] Hosp Univ Ramon & Cajal, Allergy Dept, IRYCIS, Carretera Colmenar Viejo Km 9 1, Madrid 28034, Spain
[4] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain
[5] Hosp Univ Ramon & Cajal, Dept Hematol, IRYCIS, Madrid, Spain
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2022年 / 10卷 / 05期
关键词：
MASTOCYTOSIS;
D O I：
10.1016/j.jaip.2022.01.030
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1374 / +
页数：4
相关论文
共 42 条
  • [1] Outcomes of COVID-19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders
    Giannetti, Matthew P.
    Olivieri, Francesco
    Godwin, Grace
    Weller, Emma
    Nicoloro-SantaBarbara, Jennifer
    Bonadonna, Patrizia
    Zanotti, Roberta
    Zanoni, Giovanna
    Hartmann, Karin
    Castells, Mariana
    ALLERGY, 2023, 78 (01) : 301 - 304
  • [2] Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders
    Zhu, Catherine K.
    Nguyen, Alex
    Prosty, Connor
    Gabrielli, Sofianne
    Mule, Pasquale
    Netchiporouk, Elena
    Le, Michelle
    Zhang, Xun
    Shand, Greg
    Baum, Sharon
    Hakroush, Reman
    Greenberger, Shoshana
    Ollech, Ayelet
    Miedzybrodzki, Barbara
    Ben-Shoshan, Moshe
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4937 - 4942
  • [3] Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders
    Catherine K. Zhu
    Alex Nguyen
    Connor Prosty
    Sofianne Gabrielli
    Pasquale Mulé
    Elena Netchiporouk
    Michelle Le
    Xun Zhang
    Greg Shand
    Sharon Baum
    Reman Hakroush
    Shoshana Greenberger
    Ayelet Ollech
    Barbara Miedzybrodzki
    Moshe Ben-Shoshan
    Clinical and Experimental Medicine, 2023, 23 (8) : 4937 - 4942
  • [4] Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders
    Rosman, Yossi
    Lavi, Noa
    Meir-Shafrir, Keren
    Lachover-Roth, Idit
    Cohen-Engler, Anat
    Mekori, Yoseph A.
    Confino-Cohen, Ronit
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (09) : 3487 - 3489
  • [5] Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
    Azenha Rama, T.
    Alvarez-Twose, I
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2021, 31 (02) : 193 - 195
  • [6] COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication
    Rama, Tiago Azenha
    Miranda, Joana
    Silva, Diana
    Amaral, Luis
    Castro, Eunice
    Coimbra, Alice
    Moreira, Andre
    Placido, Jose Luis
    VACCINES, 2022, 10 (05)
  • [7] Safety and Tolerability of COVID-19 Vaccine in Mast Cell Disorders Real-Life Data from a Single Centre in Italy
    Nicola, Stefania
    Mazzola, Marina
    Lo Sardo, Luca
    Montabone, Erika
    Badiu, Iuliana
    Corradi, Federica
    Azzolina, Maria Carmen Rita
    Dall'Acqua, Maurizio Gaspare
    Rolla, Giovanni
    Ridolfi, Irene
    Quinternetto, Anna
    Brussino, Luisa
    VACCINES, 2024, 12 (02)
  • [8] Insights in Anaphylaxis and Clonal Mast Cell Disorders
    Gonzalez-de-Olano, David
    Alvarez-Twose, Ivan
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [9] Mast Cell Clonal Disorders: Classification, Diagnosis and Management
    Onnes M.C.
    Tanno L.K.
    Elberink J.N.G.O.
    Current Treatment Options in Allergy, 2016, 3 (4) : 453 - 464
  • [10] COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions
    Ieven, Toon
    Vandebotermet, Martijn
    Nuyttens, Lisa
    Devolder, David
    Vandenberghe, Peter
    Bullens, Dominique
    Schrijvers, Rik
    VACCINES, 2022, 10 (02)
12345